業績

英語論文
English Articles

  • Vitamin B12 allergy manifesting as lymphomatoid contact dermatitis.
    Fujita Y, Mizukami T, Maya Y, Moriuchi R, Iwasaki S, Fukasawa Y, Shibaki A, Shimizu S
    Eur J Dermatol 30: 304-305, 2020.
  • Case of bullous erythema ab igne mimicking localized bullous pemphigoid.
    Haga N, Ujiie H, Ito T, Yamaguchi Y, Mizukami T, Katayama S, Shimizu H
    J Dermatol 47: e288-e289, 2020.
  • Clinical and immunological characterization of 14 cases of dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid: a single-centre study.
    Hayashi M, Tsunoda T, Sato F, Yaguchi Y, Igarashi M, Izumi K, Nishie W, Ishii N, Okamura K, Suzuki T, Hashimoto T
    Br J Dermatol 182: 806-807, 2020.
  • Visualization of autoantibodies and neutrophils in vivo identifies novel checkpoints in autoantibody-induced tissue injury.
    Hundt JE, Iwata H, Pieper M, Pfündl R, Bieber K, Zillikens D, König P, Ludwig RJ
    Sci Rep 10: 4509, 2020.
  • Linear IgA/IgG bullous dermatosis with autoantibodies directing the native and processed forms of BP180.
    Inamura E, Nishie W, Yamaguchi Y, Fujimura Y, Ujiie H, Natsuga K, Shimizu H
    Br J Dermatol 182: 1061-1062, 2020.
  • Case of X-linked hypohidrotic ectodermal dysplasia, along with facial bilateral reticular pigmentation.
    Kamitani T, Arase N, Nomura T, Peh JT, Wataya-Kaneda M, Katayama I, Fujimoto M
    J Cutan Immunol Allergy 3: 41-42, 2020.
  • Case of miliaria rubra histologically showing neutrophilic eccrine hidradenitis due to hyperhidrosis induced by a catecholamine-producing neuroblastoma.
    Katayama S, Iwata H, Nomura Y, Nakamura A, Yamaguchi T, Hishimura N, Nakayama K, Hashimoto K, Honda S, Shimizu H
    J Dermatol 47: e92-e93, 2020.
  • Contrast Media-Induced Iododerma Around the Eyes.
    Katayama S, Ota M
    Ophthalmology 127: 1471, 2020.
  • Two successful auricle reconstructions: A simple wedge incision and a pull-through transpositional flap.
    Kitamura S, Maeda T, Shimizu H, Yanagi T
    Dermatol Ther 33: e13301, 2020.
  • Vandetanib inhibits cell growth in EGFR-expressing cutaneous squamous cell carcinoma.
    Kitamura S, Maeda T, Yanagi T
    Biochem Biophys Res Commun 531: 396-401, 2020.
  • Drp1 expression levels correlate with clinical stage in extramammary Paget’s disease.
    Kitamura S, Yanagi T, Maeda T, Shimizu H
    J Eur Acad Dermatol Venereol 34: e510-e513, 2020.
  • Kosumi H, Natsuga K, Takashima S, Miyauchi T, Huang YT, Nomura T, Yanagi T, Huang HY, Two cases of interleukin-7 (IL-7)-deficient generalized verrucosis.Chiu FP, Chen PC, Hsu CK, Shimizu H
    Clin Infect Dis 12: 1561-1563, 2020.
  • Extramammary Paget’s disease patient-derived xenografts harboring ERBB2 S310F mutation show sensitivity to HER2-targeted therapies.
    Maeda T, Kitamura S, Nishihara H, Yanagi T
    Oncogene 39: 5867-5875, 2020.
  • RANK-RANKL signalling pathway contributes to disease progression in cutaneous angiosarcoma: a case report with an immunohistochemical review and in vitro experiments.
    Maeda T, Kitamura S, Yanagi T
    J Eur Acad Dermatol Venereol 34: e834-e837, 2020.
  • The effect of the lymphovascular plugging metastasis pattern in extramammary Paget disease on identifying metastatic lesions using imaging tests: an autopsy case series.
    Maeda T, Yoshino K, Nagai K, Oaku S, Kato M, Hiura A, Uehara J, Fujisawa Y
    Br J Dermatol 182: 493-495, 2020.
  • Speckled lentiginous nevus in a patient with Hermansky-Pudlak syndrome type 1.
    Mai S, Nishie W, Mai Y, Natsuga K, Nomura T, Suzuki S, Araki Y, Suzuki T, Shimizu H
    J Dermatol 47: e20-e21, 2020.
  • Bullous pemphigoid in a metastatic lung cancer patient associated with nivolumab.
    Maya Y MR, Takashima Y, Hotta M, Izumi H, Shimizu S
    Int J Womens Dermatol 6: 456-457, 2020.
  • Refractory juvenile psoriatic uveitis without arthritis: a literature review.
    Miyazawa H, Fujita Y, Muramatsu K, Iwata H, Nomura T, Namba K, Hoshina D, Shimizu H
    J Eur Acad Dermatol Venereol 34: e173-e175, 2020.
  • Multiple Nodules Arising within a Birthmark on the Scalp: A Quiz.
    Mizukami T, Fujita Y, Maya Y, Kawashima K, Tsuji T, Arai E, Honma K, Shimizu S
    Acta Derm Venereol 100: adv00206, 2020.
  • A recurrent subcutaneous tumour of the thumb: a case of a capicua transcriptional repressor (CIC)-rearranged sarcoma.
    Mizukami T, Yanagi T, Kitamura S, Narahira A, Maeda T, Hata H, Takakuwa E, Doi K, Sugita S, Hasegawa T, Ikenaga H, Shimizu H
    J Eur Acad Dermatol Venereol 34: e59-e61, 2020.
  • Regulatory T cell subsets in bullous pemphigoid and dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid.
    Muramatsu K, Zheng M, Yoshimoto N, Ito T, Ujiie I, Iwata H, Shimizu H, Ujiie H
    J Dermatol Sci 100: 23-30, 2020.
  • Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic-Consensus: Recommendations by an international panel of experts.
    Murrell DF, Lucky AW, Salas-Alanis JC, Woodley DT, Palisson F, Natsuga K, Nikolic M, Ramirez-Quizon M, Paller AS, Lara-Corrales I, Barzegar MA, Sprecher E, Has C, Laimer M, Bruckner AL, Bilgic A, Nanda A, Purvis D, Hovnanian A, Murat-Sušić S, Bauer J, Kern JS, Bodemer C, Martin LK, Mellerio J, Kowaleski C, Robertson SJ, Bruckner-Tuderman L, Pope E, Marinkovich MP, Tang JY, Su J, Uitto J, Eichenfield LF, Teng J, Aan Koh MJ, Lee SE, Khuu P, Rishel HI, Sommerlund M, Wiss K, Hsu CK, Chiu TW, Martinez AE
    J Am Acad Dermatol 83: 1222-1224, 2020.
  • Diagnosis and management of pemphigus: Recommendations of an international panel of experts.
    Murrell DF, Peña S, Joly P, Marinovic B, Hashimoto T, Diaz LA, Sinha AA, Payne AS, Daneshpazhooh M, Eming R, Jonkman MF, Mimouni D, Borradori L, Kim SC, Yamagami J, Lehman JS, Saleh MA, Culton DA, Czernik A, Zone JJ, Fivenson D, Ujiie H, Wozniak K, Akman-Karakaş A, Bernard P, Korman NJ, Caux F, Drenovska K, Prost-Squarcioni C, Vassileva S, Feldman RJ, Cardones AR, Bauer J, Ioannides D, Jedlickova H, Palisson F, Patsatsi A, Uzun S, Yayli S, Zillikens D, Amagai M, Hertl M, Schmidt E, Aoki V, Grando SA, Shimizu H, Baum S, Cianchini G, Feliciani C, Iranzo P, Mascaró JM, Jr., Kowalewski C, Hall R, Groves R, Harman KE, Marinkovich MP, Maverakis E, Werth VP
    J Am Acad Dermatol 82: 575-585.e1, 2020.
  • Japanese Dermatological Association Guidelines: Outlines of guidelines for cutaneous melanoma 2019.
    Nakamura Y, Asai J, Igaki H, Inozume T, Namikawa K, Hayashi A, Fukushima S, Fujimura T, Ito T, Imafuku K, Tanaka R, Teramoto Y, Minagawa A, Miyagawa T, Miyashita A, Wada M, Koga H, Sugaya M
    J Dermatol 47: 89-103, 2020.
  • Advanced malignant melanoma successfully treated with dacarbazine following anti-PD-1/CTLA-4 treatment.
    Narahira A, Yanagi T, Kitamura S, Maeda T, Hata H, Asano T, Nozaki A, Kato T, Watari H, Shimizu H
    Int J Dermatol 59: e414-e416, 2020.
  • Familial chilblain lupus with TREX1 mutation and cerebrovascular disease.
    Nohara T, Yanagi T, Yabe I, Ota N, Kanazawa N, Ujiie H, Kosumi H, Mai Y, Shimizu H
    Lancet Rheumatology 2: E724, 2020.
  • Symmetrical acral keratoderma: A waxing and waning scaly pigmented skin lesions on the acral extremities.
    Nomura T, Takeda M, Peh JT, Orita A, Inamura E, Miyauchi T, Suzuki S, Moriuchi R, Shimizu H
    J Dermatol 48: e151-e152, 2020.
  • Contribution of GATA6 to homeostasis of the human upper pilosebaceous unit and acne pathogenesis.
    Oulès B, Philippeos C, Segal J, Tihy M, Vietri Rudan M, Cujba AM, Grange PA, Quist S, Natsuga K, Deschamps L, Dupin N, Donati G, Watt FM
    Nat Commun 11: 5067, 2020.
  • Inhibition of Endoglin Exerts Antitumor Effects through the Regulation of Non-Smad TGF-β Signaling in Angiosarcoma.
    Sakamoto R, Kajihara I, Miyauchi H, Maeda-Otsuka S, Yamada-Kanazawa S, Sawamura S, Kanemaru H, Makino K, Aoi J, Makino T, Fukushima S, Masuzawa M, Masuzawa M, Amoh Y, Hoshina D, Abe R, Ihn H
    J Invest Dermatol 140: 2060-2072.e6, 2020.
  • Rosai-Dorfman disease: earlier spontaneous regression of skin lesions relative to nasal, pharyngeal, and bone lesions.
    Sato K, Ujiie H, Nakazato S, Watanabe M, Watanabe E, Yanagi T, Nakamaru Y, Takagi D, Arai R, Onodera T, Kondo T, Teshima T, Shimizu H
    Eur J Dermatol 30: 182-183, 2020.
  • Painful and Pruritic Blisters on the Lower Lip.
    Ota M
    JAMA 323: 82-83, 2020.
  • Epitope spreading possibly from BP230 to the NC16A domain of BP180 preceding disease progression in bullous pemphigoid.
    Seo T, Ujiie H, Ujiie I, Iwata H, Shimizu H
    J Dermatol 47: e255-e257, 2020.
  • Odontogenic facial cellulitis.
    Sugai T, Nishie W
    BMJ case reports 13: e239381, 2020.
  • Acquired Haemophilia A in DPP4 Inhibitor-induced Bullous Pemphigoid as Immune Reconstitution Syndrome.
    Sugiyama S, Tanaka R, Hayashi H, Izumi K, Nishie W, Aoyama Y
    Acta Derm Venereol 100: adv00178, 2020.
  • Calcinosis cutis in self-healing dominant dystrophic epidermolysis bullosa.
    Takashima S, Fujita Y, Shinkuma S, Shimizu S, Hasegawa T, Amizuka N, Shimizu H, Natsuga K
    J Dermatol 47: e457-e458, 2020.
  • A novel NCSTN missense mutation in the signal peptide domain causes hidradenitis suppurativa, which has features characteristic of an autoinflammatory keratinization disease.
    Takeichi T, Matsumoto T, Nomura T, Takeda M, Niwa H, Kono M, Shimizu H, Ogi T, Akiyama M
    Br J Dermatol 182: 491-493, 2020.
  • Plectin Missense Mutation p.Leu319Pro in the Pathogenesis of Autosomal Recessive Epidermolysis Bullosa Simplex.
    Tu WT, Chen PC, Hou PC, Huang HY, Wang JY, Chao SC, Lee JY, McGrath JA, Natsuga K, Hsu CK
    Acta Derm Venereol 100: adv00242, 2020.
  • Prevalence of infectious diseases in patients with autoimmune blistering diseases.
    Ujiie I, Ujiie H, Yoshimoto N, Iwata H, Shimizu H
    J Dermatol 47: 378-384, 2020.
  • Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial.
    Wataya-Kaneda M, Nagai H, Ohno Y, Yokozeki H, Fujita Y, Niizeki H, Yoshida K, Ogai M, Yoshida Y, Asahina A, Fukai K, Tateishi C, Hamada I, Takahata T, Shimizu K, Shimasaki S, Murota H
    Dermatol Ther 10: 635-650, 2020.
  • Loss of dynamin-related protein 1 (Drp1) does not affect epidermal development or UVB-induced apoptosis but does accelerate UVB-induced carcinogenesis.
    Yanagi T, Kitamura S, Imafuku K, Suto A, Maeda T, Tanaka S, Sesaki H, Abe R, Shimizu H
    J Dermatol Sci 99: 109-118, 2020.

日本語論文
Japanese Articles

  • Stevens-Johnson症候群と鑑別を要した多発性固定薬疹の1例.
    稲村衣美, 山口泰之, 山賀三紗子, 古屋和彦
    函館中央病院医誌: 22: 7-9, 2020.
  • 膵癌の進行に伴って再燃し関節痛を合併したpancreatic panniculitisの1例.
    宮本航大 藤, 真屋由佳, 中村路夫, 清水聡子
    市立札幌病院医誌 80: 65-70, 2020.
  • 腎移植患者548例における、水痘帯状疱疹ウイルス感染症の検討.
    高島有香, 守内玲寧, 白戸貴久, 和田吉生, 福澤信之, 原田浩, 清水聡子
    日本皮膚科学会雑誌 130: 2373-2377, 2020.
  • 体部白癬による多形紅斑の1例.
    瀬尾拓志, 宮澤元, 佐藤英嗣
    帯広厚生病院医誌 22: 66-69, 2020.
  • 急速に間質性肺炎が進行した抗MDA5抗体陽性皮膚筋炎の2例.
    白戸貴久, 野村友希子
    KKR札幌医療センター医学雑誌 17: 51-55, 2020.
  • 融合性細網状乳頭腫症の2例.
    保科大地, 堀田萌子, 笠井潔
    日本臨床皮膚科医会雑誌 37: 359, 2020.

総説
Reviews

  • Collagen XVII Processing and Blistering Skin Diseases.
    Nishie W
    Acta Derm Venereol 100: adv00054, 2020.
  • Recombination-induced revertant mosaicism in ichthyosis with confetti and loricrin keratoderma.
    Nomura T
    J Dermatol Sci 97: 94-100, 2020.
  • 自己免疫性水疱症の診断の最前線.
    氏家英之
    検査と技術 48: 10-13, 2020.
  • 表皮水疱症.
    氏家英之
    今日の治療指針 2020年版-私はこう治療している-. 東京: 医学書院. 2020. pp 1287-1288.
  • 表皮水疱症の培養表皮シートを用いた治療戦略.
    藤田靖幸
    臨床皮膚科 74: 109-113, 2020.
  • 急性汎発性発疹性膿疱症.
    椎谷千尋, 高橋勇人
    調剤と情報, 26. 86-90, 2020.
  • 皮脂欠乏性湿疹.
    乃村俊史
    medicina 57: 1870-1871, 2020.
  • 【”中毒疹”診断のロジックと治療】ヘリコバクター・ピロリ菌除菌療法後にみられる皮疹.
    伊東孝政
    Monthly Book Derma 296: 48-56, 2020.
  • 【日常診療で接する薬剤性皮膚障害】(Part1.)糖尿病治療薬による薬疹(case1) DPP-4阻害薬内服患者に生じた水疱性類天疱瘡の1例.
    葭本倫大, 氏家英之
    Visual Dermatology 19: 140-142, 2020.
  • 【”顔の赤み”鑑別・治療アトラス】菌状息肉症による顔面紅斑 局面・腫瘤形成をきたした2例.
    葭本倫大
    Monthly Book Derma 294: 197-202, 2020.

著書・その他
Authors and others

  • Acantholytic vesicular dermatitis, subcorneal.
    藤田靖幸
    皮膚病理のすべてII: 炎症性皮膚疾患. 東京: 文光堂. 2020. pp154-161.
  • Pustular dermatitis, subepidermal, eosinophils prominent
    藤田靖幸
    皮膚病理のすべてII: 炎症性皮膚疾患. 東京: 文光堂. 2020. pp170-177.
  • プラタナス~私のカルテから~ これ塗ると犬が調子悪くなるんだよね.
    藤田靖幸
    日本医事新報 5024: 3, 2020.
  • なぜ頭は治りにくいか?.
    藤田靖幸
    乾癬・掌蹠膿疱症 病態の理解と治療最前線. 東京: 中山書店. 2020. pp 182-183.
  • アトピー性皮膚炎診療ガイドライン2018年版(解説).
    藤田靖幸, 清水宏
    今日の治療指針2020,福井次矢, 高木 誠, 小室一成編, 医学書院, 2020,: p2043-2047, 2020.
  • リレーエッセイ 私のワークライフバランス 継続を力にかえて.
    清水聡子
    皮膚病診療 42: 1012-1013, 2020.
  • プラタナス~私のカルテから~ 匍匐前進.
    保科大地
    日本医事新報 4999: 3, 2020.
  • アクロコルドン(スキンタッグ,軟性線維腫).
    須貝達朗
    日本医事新報 4998: 40, 2020.
  • 黄色調の皮膚腫瘍
    柳輝希
    今日の皮膚疾患治療指針 第5版, 2020.
  • 生物学的製剤によるパラドキシカル反応.
    伊藤圭
    乾癬・掌蹠膿疱症 病態の理解と治療最前線. 東京: 中山書店. 2020. pp 230-231.
  • IL-23阻害薬.
    伊藤圭
    皮膚疾患 全身療法薬 Up-to-date. 東京: 南江堂. 2020. pp 24-27.
  • 乾癬テーラーメイド治療+プラセボ効果治療.
    伊藤圭
    Psoriasis Info Letter:7 ソラコラ(Psoriasis Column): 9, 2020.